How much does Botox Cost?
Posted on November 6, 2015
How much does Botox Cost? Botox is one of the most popular anti-aging non-surgical aesthetic treatments for the face. This injectable treatment may be recommended for individuals who wish to avoid cosmetic surgery, but still want to find a solution to minimize facial lines and wrinkles. During the initial consultation, the Botox treatment provider will […]
What is Botox Used for?
Posted on November 2, 2015
What is Botox Used for? Botox offers a safe, standout, and proven non-surgical solution for facial aging. Ever since the Botox injection procedure was approved by the FDA for cosmetic reduction of fine lines on the forehead and between the eyes, it has continued to remain the most sought after anti-aging procedure around the world. […]
Who is Administering Your Botox? Why Credentials Matter
Posted on July 3, 2015
Botox Botox is a proven and highly effective anti-aging non-surgical aesthetics treatment to reduce fine lines and wrinkles on the face. Tens of millions of patients around the world benefit from this treatment every year to achieve a more youthful looking face without have to undergo cosmetic surgery. The FDA gave approval to Botox in […]
New fillers on the horizon: Juvederm Voluma
Posted on May 2, 2013
Here in the U.S.A., it seems we’re the last to get new medical devices. Sometimes, that’s a good thing – as in the FDA preventing the notoriously problematic PIP silicone breast implants from being sold here. Other times, it’s just a frustrating and slow wait for good products. As a plastic surgeon, you can feel […]
Botox versus Dysport
Posted on January 17, 2012
This month, in the ASJ, comes another study looking at the Botox versus Dysport battle. Patients are always wondering – “which one is best?”. Some patients swear they do better with one medication compared to the other.In this paper, a randomized, controlled study, 53 patients had Botox on one side of the face, and Dysport on the […]
Valeant Pharmaceuticals buys Sculptra
Posted on December 12, 2011
In a $425 million deal, Valeant Pharmaceuticals has purchased the dermatology unit of Sanofi-Adventis. For us, this means that Valeant will now be in charge of marketing Sculptra, the facial injectable filler agent. Sculptra is different than other dermal injectable fillers, like Restylane or Juvederm. It stimulates your body to produce some lost collagen, which […]
Is Xeomin better than Botox? Or is Dysport the best?
Posted on October 29, 2011
With the advent of the new botulinum preparation called Xeomin, many people are wondering which one is better – Botox, Dysport or Xeomin? Here’s what we know, scientifically speaking: 1) A comparison study (here) of Botox versus Xeomin for wrinkles in the glabella (frown lines) found these two products to work virtually the same, according to […]
FDA approves Restylane (officially) for lip augmentation
Posted on October 14, 2011
The U.S. Food and Drug Administration (FDA) has approved another use for Restylane Injectable Gel: this week the agency gave its official blessing to use the filler for lip augmentation. Restylane was previously approved to treat facial wrinkles. While we have long used it for lip augmentation, this was known as an unofficial or “off-label” […]
How about some Free Botox? – our new “Botox buddy” special
Posted on October 3, 2011
Free botox – sounds too good to be true, right? Of course, there’s a catch – but for the month of October 2011, we’re offering a simply unbeatable deal. We want our loyal friends & customers to help us “spread the word” about our Botox services – so we’ve cooked up this fantastic “Botox buddy” October promotion […]
Botox, Dysport and now…Xeomin
Posted on July 26, 2011
Just this week, the FDA has approved another competitor for Botox. This one is called Xeomin, and it’s sold by Merz Aesthetics. Just like Botox and Dysport, it temporarily reduces wrinkle lines, such as the frown lines between the eyebrows. However, Xeomin does not require refrigeration prior to reconstitution and mixing. According to the manufacturer’s press […]